Cookie technology helps us bring you the best possible experience when you visit this website. Please let us know if you're happy to accept cookies. To learn more about our policy on cookies, please review our privacy policy via the link at the bottom of the page.

Our other therapy areas

    • {%buzitemName%}
        {%buzbrandMenuItems%}
    • {%bitemName%} {%barrowSpan%}
        {%bsubBrandMenuItems%}
    • {%sbitemName%} {%sbarrowSpan%}
        {%sbproductMenuItems%}
    • {%pitemKeyName%} {%pitemBadges%} {%parrowSpan%}
      {%pselfProduct%}
    • {%mNavitemName%}
      • {%lScountries%}
    • {%allMenuItem%}
      • {%cSlanguages%}

      • Africa

      Asia Pacific

      Europe

      Middle East

      North America

      Latin America / Caribbean

      South America

      test

      AbbViePro Logo 2023
      MENU
      Log in
      or
      Register
      Log in
      or
      Register

      STAY INFORMED > Sign up to stay up-to-date about myelofibrosis

       

       

       

       

       

       

       

      The disease is more than physical symptoms.

      HOW LONG BEFORE

      MYELOFIBROSIS

      TAKES OVER?

      Rethink this progressive disease >

       

       

       

       

       

      JAK/STAT=janus kinase/signal transducer and activator of transcription; MF=myelofibrosis.

      This website is intended for [countryName] Healthcare Professionals

      Copyright © 2018 AbbVie Inc. North Chicago, Illinois, U.S.A.

      Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.

      Data of Preparation: December 2018

      Approval code [approvalCode]

      img
      img
      Our therapy areas
      Immunology
      Oncology
      Neurology
      Virology
      Our therapy areas
      Immunology
      Oncology
      Neurology
      Virology
      Additional info
      Privacy Policy
      Terms and Conditions
      Manage Cookies
      Contact Us
      Additional info
      Privacy Policy
      Terms and Conditions
      Manage Cookies
      Contact Us
      This website is intended for Healthcare Professionals

      Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.

      This website is intended for Italy Healthcare Professionals

      Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.

      Date of Preparation: December 2018  |   Approval code AT-ABBV-210058 Aug 21    |    Copyright © 2018 AbbVie Inc. North Chicago, Illinois, U.S.A.

      Date of Preparation: December 2018 

      Approval code AT-ABBV-210058 Aug 21

      Copyright © 2018 AbbVie Inc. North Chicago, Illinois, U.S.A.